PRESS RELEASE published on 03/05/2025 at 06:30, 8 months 30 days ago Helvetica Swiss Opportunity Fund Records Strong Portfolio Income in the 2024 Financial Year and is Ready to be Merged with the HSC Fund Helvetica Swiss Opportunity Fund (HSO Fund) reports solid performance in 2024 financial year, enhancing portfolio income and debt ratio, preparing for merger with HSC Fund Merger Financial Year Helvetica Swiss Opportunity Fund Debt Financing Ratio Portfolio Income
BRIEF published on 02/28/2025 at 06:35, 9 months 4 days ago Merger Details Confirmed for Helvetica Funds Merger Real Estate Helvetica Property FINMA Approval Swiss Funds
PRESS RELEASE published on 02/28/2025 at 06:30, 9 months 4 days ago Merger schedule for the Helvetica Swiss Opportunity Fund and Helvetica Swiss Commercial Fund is in place Merger schedule approved by FINMA for Helvetica Swiss Opportunity Fund and Helvetica Swiss Commercial Fund for a more diversified and liquid commercial property fund Merger Property Fund Commercial Real Estate Swiss Market FINMA
BRIEF published on 02/10/2025 at 06:35, 9 months 22 days ago Marc Escher Appointed at Helvetica Property Chief Financial Officer Appointment Financial Stability Helvetica Property Marc Escher
PRESS RELEASE published on 02/10/2025 at 06:30, 9 months 22 days ago Helvetica puts its trust in targeted expertise: Marc Escher is the new Chief Financial Officer Helvetica appoints Marc Escher as new Chief Financial Officer, reinforcing strategic focus on financial stability and sustainable growth Chief Financial Officer Sustainable Growth Financial Stability Helvetica Marc Escher
BRIEF published on 02/06/2025 at 06:35, 9 months 26 days ago Helvetica Swiss Opportunity Fund to go public soon Real Estate Investment Net Asset Value IPO SIX Swiss Exchange Helvetica Swiss Opportunity Fund
PRESS RELEASE published on 02/06/2025 at 06:30, 9 months 26 days ago Helvetica announces indicative NAV estimate for end of 2024 in view of IPO of Helvetica Swiss Opportunity Fund on 11 February 2025 Helvetica announces indicative NAV estimate for end of 2024 in view of IPO of Helvetica Swiss Opportunity Fund on 11 February 2025. Fund management discloses NAV ahead of SIX Swiss Exchange listing IPO SIX Swiss Exchange Helvetica Swiss Opportunity Fund NAV Estimate
BRIEF published on 01/14/2025 at 06:35, 10 months 21 days ago Helvetica Swiss Opportunity Fund: IPO in February 2025 IPO SIX Swiss Exchange Real Estate Fund Strategic Merger Business Investment
PRESS RELEASE published on 01/14/2025 at 06:30, 10 months 21 days ago Helvetica Swiss Opportunity Fund now open to public investors and due to be listed on the stock exchange in February 2025, with a view to merging with the HSC Fund Helvetica Swiss Opportunity Fund, approved by FINMA, to be listed on SIX Swiss Exchange on 11 February 2025. Merger with HSC Fund to follow. Fund offers value through stable real estate assets Merger SIX Swiss Exchange FINMA Helvetica Swiss Opportunity Fund
BRIEF published on 12/19/2024 at 06:35, 11 months 16 days ago Strategic sales of Helvetica Swiss Opportunity Fund in preparation for IPO IPO Fusion Real Estate Sale Helvetica Wallet
Published on 12/05/2025 at 02:35, 3 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025